Myriad Genetics Inc
NASDAQ: MYGN
$28.60
+$0.70 (+2.5%)
Closing Price on September 17, 2024
MYGN Articles
ThinkstockThe U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body. In its ruling, the court also ruled that synthetic molecules...
Published:
Last Updated:
Investors and traders are always searching for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas...
Published:
Last Updated:
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from...
Published:
Last Updated:
ThinkstockMyriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad’s gene sequencing tested positive for the...
Published:
ThinkstockIn theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling...
Published:
Last Updated:
Investors and traders are always on the lookout for fresh Wall Street research ideas of stocks to buy, value stocks and dividend stocks. 24/7 Wall St. reviews many fresh research calls to find great...
Published:
Last Updated:
ThinkstockShould a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc. (NASDAQ: MYGN). This company and its stock are at the center of a multi-year...
Published:
The negative fourth-quarter gross domestic product (GDP) reading of -0.1% caught most Wall St. analysts and economists by surprise. This unforeseen number was skewed by a huge decrease in government...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Wednesday. American Campus Communities Inc. (NYSE: ACC) raised to Buy at UBS....
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Automatic Data Processing Inc. (NASDAQ: ADP) cut to Neutral at UBS. Bank...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Avon Products Inc. (NYSE: AVP) Cut to Sell at UBS. Bank of America Corporation...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Adtran Inc. (NASDAQ: ADTN) Reiterated Buy and $39 target at Argus. Apple Inc....
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Altera Corporation (NASDAQ: ALTR) Cut to Neutral at Citigroup. Bank of...
Published:
Last Updated:
The pace of stock buyback announcements in the month of August was almost unbelievable. The pace was stronger at the start of the month when earnings were still coming in droves, but the number of...
Published:
Last Updated: